Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 110 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Leonid K.

United States

USD 110 /hr

Clinical Scientist | MD | Biomarker & Oncology Trials Expert | IND/BLA | Translational Research

Profile Summary

I am a medical doctor and clinical research expert with over a decade of experience in oncology, translational science, and early-phase clinical development. My focus has been on biomarker-driven trials, TCR-T and CAR-T therapies, immuno-oncology, and regulatory strategy (IND/BLA). I’ve worked across academic, biotech, and pharma settings, collaborating on clinical trial design, protocol development, data interpretation, and submissions to FDA/EMA. I provide consulting on: Clinical protocol review (oncology, cell therapy, IO) Biomarker strategy and translational endpoints IND/BLA documentation (CTD sections, safety, efficacy summaries) Scientific writing: publications, abstracts, white papers Regulatory response drafting I combine scientific rigor with a patient-first mindset and deep experience navigating complex, fast-paced studies.

Subject Matter Expertise

• ☆ Pharmacovigilance/Drug Safety Monitoring
• ☆ Oncology
• ☆ Radiation Therapy
• ☆ Chemotherapy
• ☆ Surgical Oncology
• ☆ Precision Medicine
• ☆ Pediatric Oncology
• ☆ General Surgery
• ☆ Hematology
• ☆ Hematology-Oncology
• ☆ Leukemia & Lymphoma
• ☆ Clinical Laboratory Science
• ☆ Clinical Pathology
• ☆ Hemophilia
• ☆ Musculoskeletal Oncology
• ☆ Neuro-Oncology

Services

• Writing
• Research
• Consulting

Writing Medical Writing

Research Fact Checking, Scientific and Technical Research, Systematic Literature Review

Consulting Healthcare Consulting, Scientific and Technical Consulting, Manufacturing Consulting

Work Experience

Fox Chase Cancer Center

- Present

Senior Clinical Scientist

Boston Gene

January 2024 - October 2024

Clinical Scientist

Fox Chace Cancer Center

August 2019 - January 2023

Clinical Development Director

Vida Dynamics

January 2018 - January 2023

Oncologist / Clinical Trials Unit Lead

National Medical Research Center for Oncology

January 2014 - January 2023

Medical Advisor / Clinical Development Consultant

Novartis

January 2017 - January 2018

Medical Advisor / Clinical Development Consultant

Janssen Pharmaceuticals

January 2014 - January 2016

Education

Medical Degree (MD)

Rostov State Medical University - Russian Federation

January 2005 - January 2011

Certifications

• Medical Oncology

  National Medical Research Center for Oncology

  January 2018 - January 2023

Publications

JOURNAL ARTICLE

Khabibov M, Garifullin A, Sadreeva A, Fernandez MF, Kashaev M, Topchu I, Kharin L, Boumber Y(2025). Functional and Clinical Relevance of the Crosstalk between the Glymphatic System and the Lymphatic System . Current neuropharmacology.

Leonid Kharin, Marsel Khabibov, Airat Garifullin, Yanis Boumber, Karam Khaddour, Manuel Fernandez, Firat Khamitov, Larisa Khalikova, Natalia Kuznetsova, Oleg Kit (2022). Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review) . International Journal of Oncology.

Leonid Kharin, Punita Dhawan, Igor Bychkov, Nikolay Karnaukhov, Mark Voloshin, Rushaniya Fazliyeva, Alexander Deneka, Elena Frantsiyants, Oleg Kit, Erica Golemis, et al. (2021). Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression . PLOS ONE.

Topchu I, Karnaukhov N, Mazitova A, Yugai V, Voloshin M, Tikhomirova M, Kit O, Frantsiyants E, Kharin L, Airapetova T, et al.(2021). Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC) . Journal of thoracic disease.

Makhov P, Bychkov I, Faezov B, Deneka A, Kudinov A, Nicolas E, Brebion R, Avril E, Cai KQ, Kharin LV, et al.(2021). Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC) . Oncogenesis.

Beck TN, Kharin LV, Kit OI, Dulaimi E, Boumber Y(2018). Miliary Adenocarcinoma of the Lung Responds to Gefitinib and Afatinib . Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Kit OI, Vodolazhsky DI, Kutilin DS, Enin YS, Gevorkyan YA, Zolotukhin PV, Boumber Y, Kharin LV, Panina SB(2017). A Proteomics Analysis Reveals 9 Up-Regulated Proteins Associated with Altered Cell Signaling in Colon Cancer Patients . The protein journal.